Erhalte mehr Antworten von Arbeitgebern
Versende in nur wenigen Minuten einen passgenauen Lebenslauf.
The University Hospital of Cologne is seeking a PhD Student (f/m/x) for an embedded project in the CRC 1530 on pathogenic mechanisms in B cell malignancies. The position is fully funded, limited until 31 December 2029, with salary based on TV-L EG 13 and 38.5 hours per week.
You will perform molecular and cellular biology work on patient samples and models, visualize data, and present results. Close collaboration with clinical and computational teams is expected.
We are looking to support our rapidly growing team as soon as possible:
Innere Medizin -Collaborative Research Center (CRC) 1530 Elucidation and targeting of pathogenic mechanisms in B cell malignancies, Research Project B01 (Dr. Laura Beckmann, Prof. Michael Hallek)
TV-L: 38,5 h/week (100%)
limited until December 31, 2029 according to WissZeitVG within the framework of a third-party funded project
Your salary will be based on TV-L EG 13
TV-L: 38,5 h/week (100%)
limited until December 31, 2029 according to WissZeitVG within the framework of a third-party funded project
Your salary will be based on TV-L EG 13
We are one of the leading university hospitals in Germany and network research, teaching and health care at the highest level. That's why many things are a lot bigger for us: the spectrum of exciting development opportunities. The limitless openness with which specialists from all over the world work together here. Or our commitment as an employer to support all employees as best we can in reconciling their job with their goals and life situations.
This is the University Hospital of Cologne: Everything but ordinary.
We are looking for a PhD for a fully-funded (DFG)
basic/translational science project on the molecular and
cellular mechanisms of the microenvironment in chronic
lymphocytic leukemia. This project is embedded into the
collaborative research center (CRC) 1530 – "Elucidation and targeting of pathogenic mechanisms in B cell malignancies" and will be co-mentored by Dr. Laura Beckmann and Prof. Michael Hallek. As a part of this interdisciplinary research consortium, we will utilize primary patient CLL samples as well as pre-clinical in vitro and murine in vivo models to interfere with the lymphoma supportive microenvironmental niche by perturbing
microenvironmental signaling within the microenvironment and CLL cells. This PhD project focuses on investigating the role of the tumor microenvironment in chronic lymphocytic leukemia (CLL). The research
combines molecular and cellular biology approaches with in vivo murine models, novel spatial technologies, and clinical correlatives to elucidate the mechanisms governing CLL progression. The project is jointly supervised by two principal investigators with complementary expertise in basic and translational lymphoma research. The laboratory is based at the CECAD Research Center on the Medical
Campus of the University of Cologne, providing a collaborative and interdisciplinary research environment with access to state-of-the-art technologies.
People with disabilities are welcome to apply and will be treated preferentially in the event of equal suitability and qualification. The position is suitable for staffing with part-time employees.
Tel:+49 221 478-88834
Contact Team Bewerbungsmanagement